Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Biologicals : Journal of the International Association of Biological Standardization
|
December 26, 2016
Physicochemical characterization and immunological properties of Pichia pastoris based HPV16L1 and 18L1 virus like particles
Gaurav Gupta, Reinhard Glueck, Narayan Rishi
Human Vaccines & Immunotherapeutics
|
April 1, 2017
HPV vaccines: Global perspectives
Gaurav Gupta, Reinhard Glueck, Pankaj R Patel
Vaccine
|
August 16, 2016
Immunogenicity of next-generation HPV vaccines in non-human primates: Measles-vectored HPV vaccine versus Pichia pastoris recombinant protein vaccine
Gaurav Gupta, Viviana Giannino, Narayan Rishi, et al.
Advances in Experimental Medicine and Biology
|
January 5, 2010
New strategies to overcome the drawbacks of currently available flu vaccines
Epifanio Fichera, Diana Felnerova, Robert Mischler, et al.
Vaccine
|
February 10, 2009
Recombinant measles virus-HPV vaccine candidates for prevention of cervical carcinoma
Giuseppina Cantarella, Matthias Liniger, Armando Zuniga, et al.
Human Vaccines & Immunotherapeutics
|
April 1, 2017
Immunogenicity and safety of a novel MMR vaccine (live, freeze-dried) containing the Edmonston-Zagreb measles strain, the Hoshino mumps strain, and the RA 27/3 rubella strain: Results of a randomized, comparative, active controlled phase III clinical trial
Ashwani Sood, Monjori Mitra, Himanshu Arvind Joshi, et al.
Vaccine
|
February 17, 2007
Attenuated measles virus as a vaccine vector
Armando Zuniga, Zili Wang, Matthias Liniger, et al.
Human Vaccines & Immunotherapeutics
|
February 21, 2018
Immunogenicity and safety of the first indigenously developed Indian tetravalent influenza vaccine (split virion) in healthy adults ≥ 18 years of age: A randomized, multicenter, phase II / III clinical trial
Shrikant Sharma, Veer Bahadur Singh, Sanjay Kumar, et al.
Plos Neglected Tropical Diseases
|
November 28, 2017
Pre-clinical antigenicity studies of an innovative multivalent vaccine for human visceral leishmaniasis
Pedro Cecílio, Begoña Pérez-Cabezas, Laura Fernández, et al.
Microorganisms
|
November 27, 2021
Protective Efficacy in a Hamster Model of a Multivalent Vaccine for Human Visceral Leishmaniasis (MuLeVaClin) Consisting of the KMP11, LEISH-F3+, and LJL143 Antigens in Virosomes, Plus GLA-SE Adjuvant
Laura Fernández, Jose Carlos Solana, Carmen Sánchez, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Biologicals : Journal of the International Association of Biological Standardization
|
December 26, 2016
Physicochemical characterization and immunological properties of Pichia pastoris based HPV16L1 and 18L1 virus like particles
Gaurav Gupta, Reinhard Glueck, Narayan Rishi
Human Vaccines & Immunotherapeutics
|
April 1, 2017
HPV vaccines: Global perspectives
Gaurav Gupta, Reinhard Glueck, Pankaj R Patel
Vaccine
|
August 16, 2016
Immunogenicity of next-generation HPV vaccines in non-human primates: Measles-vectored HPV vaccine versus Pichia pastoris recombinant protein vaccine
Gaurav Gupta, Viviana Giannino, Narayan Rishi, et al.
Advances in Experimental Medicine and Biology
|
January 5, 2010
New strategies to overcome the drawbacks of currently available flu vaccines
Epifanio Fichera, Diana Felnerova, Robert Mischler, et al.
Vaccine
|
February 10, 2009
Recombinant measles virus-HPV vaccine candidates for prevention of cervical carcinoma
Giuseppina Cantarella, Matthias Liniger, Armando Zuniga, et al.
Human Vaccines & Immunotherapeutics
|
April 1, 2017
Immunogenicity and safety of a novel MMR vaccine (live, freeze-dried) containing the Edmonston-Zagreb measles strain, the Hoshino mumps strain, and the RA 27/3 rubella strain: Results of a randomized, comparative, active controlled phase III clinical trial
Ashwani Sood, Monjori Mitra, Himanshu Arvind Joshi, et al.
Vaccine
|
February 17, 2007
Attenuated measles virus as a vaccine vector
Armando Zuniga, Zili Wang, Matthias Liniger, et al.
Human Vaccines & Immunotherapeutics
|
February 21, 2018
Immunogenicity and safety of the first indigenously developed Indian tetravalent influenza vaccine (split virion) in healthy adults ≥ 18 years of age: A randomized, multicenter, phase II / III clinical trial
Shrikant Sharma, Veer Bahadur Singh, Sanjay Kumar, et al.
Plos Neglected Tropical Diseases
|
November 28, 2017
Pre-clinical antigenicity studies of an innovative multivalent vaccine for human visceral leishmaniasis
Pedro Cecílio, Begoña Pérez-Cabezas, Laura Fernández, et al.
Microorganisms
|
November 27, 2021
Protective Efficacy in a Hamster Model of a Multivalent Vaccine for Human Visceral Leishmaniasis (MuLeVaClin) Consisting of the KMP11, LEISH-F3+, and LJL143 Antigens in Virosomes, Plus GLA-SE Adjuvant
Laura Fernández, Jose Carlos Solana, Carmen Sánchez, et al.
Page
of 1